New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
04:55 EDTATOS, ATOS, RHHBY, RHHBY, SQNM, SQNM, GHDX, GHDX, SAP, SAP, AET, AET, IBM, IBM, UNH, UNHPMWC, Inc to host a conference
Personalized Medicine World Conference is being held in Mountain View, California on January 28-29.
News For ATOS;RHHBY;SQNM;GHDX;SAP;AET;IBM;UNH From The Last 14 Days
Check below for free stories on ATOS;RHHBY;SQNM;GHDX;SAP;AET;IBM;UNH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 13, 2014
19:59 EDTIBMImperva faces competition from firms like IBM, F5 Networks, Bloomberg says
Subscribe for More Information
April 11, 2014
10:05 EDTAETAetna, Tenet form accountable care collaboration in San Antonio
Aetna (AET), Tenet’s (THC) Baptist Health System and HealthTexas Medical Group announced an accountable care collaboration and the introduction of the Aetna Whole Health product in the San Antonio area. The health plans, designed for fully insured customers with employees who live or work in Bexar, Guadalupe, Comal and Kendall counties, will be available on July 1.
07:57 EDTIBMIBM April volatility elevated at 37 into Q1
Subscribe for More Information
April 10, 2014
14:24 EDTIBMAmazon Web Services CTO says ARM CPUs may be considered, The Register says
Amazon (AMZN) Web Services chief technology officer Werner told The Register that the company is “always looking for efficiency” and may consider using ARM (ARMH) CPUs in the future. Vogels said another processor architecture AWS has considered is IBM's (IBM) Power, the report noted. Reference Link
11:42 EDTRHHBYReport claims Tamiflu, Relenza do little to prevent the spread of flu
Subscribe for More Information
10:00 EDTIBMOn The Fly: Analyst Initiation Summary
Apple (AAPL) initiated with a Buy at Deutsche Bank... Crocs (CROX) initiated with a Buy at Buckingham... Deckers Outdoor (DECK) initiated with a Buy at Buckingham... EMC (EMC) initiated with a Buy at Deutsche Bank... HP (HPQ) initiated with a Buy at Deutsche Bank... IBM (IBM) initiated with a Hold at Deutsche Bank... NeoPhotonics (NPTN) coverage resumed with a Market Perform at Raymond James... NetApp (NTAP) initiated with a Hold at Deutsche Bank... Nutrisystem (NTRI) initiated with a Buy at B. Riley... Questar (STR) initiated with an Underperform at BofA/Merrill... S&T Bancorp (STBA) initiated with an Outperform at Raymond James... STB Systems Inc (STBI) initiated with an Outperform at Raymond James... Skechers (SKX) initiated with an Underperform at Buckingham... Steven Madden (SHOO) initiated with a Buy at Buckingham... UGI Corporation (UGI) initiated with a Buy at BofA/Merrill... Web.com (WWWW) initiated with a Neutral at Buckingham... Ally Financial (ALLY) initiated with a Buy at BTIG... Visteon (VC) initiated with a Buy at Citigroup... Greatbatch (GB) initiated with a Buy at KeyBanc... Steris (STE) initiated with a Buy at KeyBanc... Cooper Companies (COO) initiated with a Hold at KeyBanc... Hill-Rom (HRC) initiated with a Hold at KeyBanc... Invacare (IVC) initiated with a Hold at KeyBanc... Teleflex (TFX) initiated with a Hold at KeyBanc... Provident Financial (PROV) initiated with a Market Perform at Keefe Bruyette... UMH Properties (UMH) initiated with a Hold at Wunderlich.
09:06 EDTIBMIBM to acquire Atlanta-based software company Silverpop
Subscribe for More Information
08:44 EDTIBMCLSA technology analysts hold an analyst/industry conference call
Subscribe for More Information
06:55 EDTIBMIBM initiated with a Hold at Deutsche Bank
Subscribe for More Information
05:40 EDTSAPAccenture, SAP expand global alliance through first-of-its-kind agreement
Subscribe for More Information
April 9, 2014
09:35 EDTSAPSAP mentioned cautiously at OTR Global
April 8, 2014
16:10 EDTRHHBYProthena says first human dosed in Phase 1 study of PRX002
Prothena (PRTA) announced the successful start of a Phase 1 clinical trial of its therapeutic monoclonal antibody candidate, PRX002, for the treatment of Parkinson's disease. Prothena has earned a $15M milestone payment from Roche (RHHBY) related to the initiation of this study. The initial Phase 1 clinical trial of PRX002 is a randomized, double-blind, placebo-controlled, single ascending dose study in healthy subjects. It is designed to assess PRX002 for safety, tolerability, pharmacokinetics and immunogenicity. As previously announced in December 2013, Prothena entered into a worldwide collaboration with Roche to develop and commercialize antibodies that target α-synuclein, including PRX002. Including the current milestone payment, Prothena has now achieved a total of $45M through its worldwide PRX002 collaboration with Roche.
11:03 EDTRHHBYPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
10:18 EDTUNH, AETCMS says Medicare Advantage reimbursement to rise in 2015
Subscribe for More Information
09:23 EDTAET, UNHLeerink views final rates as favorable for MA plans
Subscribe for More Information
07:28 EDTIBMSecurity Innovation Network to hold a forum
IT Security Entrepreneurs Forum: ITSEF 2014 is being held in Mountain View, California on April 8-9.
07:22 EDTSQNMCaSA-ISPE to hold a conference
21st Annual Lilfe Sciences Technology Conference is being held in Raleigh, North Carolina on April 8.
April 7, 2014
19:13 EDTUNH, AETCMS issues 2015 rate announcement for Medicare Advantage and Part D programs
Subscribe for More Information
10:10 EDTIBM, SAPAnalyst sees 'golden' opportunity after software stocks decline
Subscribe for More Information
06:07 EDTRHHBYRoche acquires IQuum for $450M
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use